Engineered probiotics Clostridium butyricum‐pMTL007‐GLP‐1 improves blood pressure via producing GLP‐1 and modulating gut microbiota in spontaneous hypertension rat models

Hypertension is a significant risk factor of cardiovascular diseases (CVDs) with high prevalence worldwide, the current treatment has multiple adverse effects and requires continuous administration. The glucagon‐like peptide‐1 receptor (GLP‐1R) agonists have shown great potential in treating diabete...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xin‐liang, Chen, Wen‐jie, Jin, Rui, Xu, Xuan, Wei, Jing, Huang, Hong, Tang, Yan‐hua, Zou, Chang‐wei, Chen, Ting‐tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034621/
https://www.ncbi.nlm.nih.gov/pubmed/36528874
http://dx.doi.org/10.1111/1751-7915.14196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034621/
https://www.ncbi.nlm.nih.gov/pubmed/36528874
http://dx.doi.org/10.1111/1751-7915.14196

Ejemplares similares